medigraphic.com
ISSN 2448-8747 (Print)
Publicación cuatrimestral editada por la Secretaría de Salud Jalisco

2025, Number 1

<< Back Next >>

Sal Jal 2025; 12 (1)

Evaluation of respiratory function with spirometry in post-COVID-19 patients, ISSSTE beneficiaries, Jalisco Delegation, 2021

Báez-Báez MGL, De SAI, Muñiz-Mendoza P

Language: Spanish
References: 18
Page: 13-18
PDF size: 529.16 Kb.


ABSTRACT

Introduction: COVID-19 is a disease that has acute symptoms such as fever, cough, and dyspnea, followed by pneumonia and bilateral interstitial involvement. One third of patients developed Acute respiratory distress syndrome (ARDS), which can result in death or slow recovery from pulmonary complications. This descriptive cross-sectional study evaluated respiratory restriction using spirometry in 89 patients with COVID-19 enrolled in ISSSTE from January to May 2021. Material and methods: variables considered age, sex, weight, respiratory function. Results: age from 28 to 70 years, with an average of 51.6 years, female predominance with a 2.4:1 female/male ratio. Respiratory restriction was identified in 31.4% of the subjects; 28.6% had mild obstruction, 10.7% moderate obstruction, and 7.1% respiratory restriction. Body mass index (BMI), 31.5% of subjects with overweight, 49.4% with mild, medium or morbid obesity. In the BMI in relation to respiratory restriction, the presence of respiratory restriction was observed in any of the BMI degrees, with a higher percentage in overweight (11.2%) and mild obesity (7.8%). BMI and age in relation to respiratory restriction were not statistically significant, while sex had a p = 0.02, indicating an association between respiratory restriction and being male or female. Conclusion: spirometry reported probable respiratory restriction or respiratory restriction in 31.4% of post-COVID-19 ISSSTE beneficiaries, with a statistically significant association with sex.


REFERENCES

  1. Salinas-Aguirre JE, Sánchez-García C, Rodríguez-Sanchez R, Rodríguez-Muñoz L, Díaz-Castaño A, Bernal-Gómez R. Clinical characteristics and comorbidities associated with mortality in patients with COVID-19 in Coahuila (Mexico). Rev Clin Esp (Barc). 2022;222(5):288-292.

  2. Suárez V, Suarez Quezada M, Oros Ruiz S, Ronquillo De Jesús E. Epidemiología de COVID-19 en México: del 27 de febrero al 30 de abril de 2020. Rev Clin Esp. 2020;220(8):463-471.

  3. Secretaría de Salud. Panorama internacional de la pandemia. Informe integral de COVID-19 en México [Internet]. Número 1. México: Secretaría de Salud; 2022. pp. 13-17.

  4. Machhi J, Herskovitz J, Senan AM, Dutta D, Nath B, Oleynikov MD, et al. The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J Neuroimmune Pharmacol. 2020;15(3):359-386.

  5. Chérrez-Ojeda I, Gochicoa-Rangel L, Salles-Rojas A, Mautong H. Seguimiento de los pacientes después de neumonía por COVID-19. Secuelas pulmonares. Rev Alerg Méx. 2020;67(4):350-369.

  6. Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026.

  7. George PM, Barratt SL, Condliffe R, Desai SR, Devaraj A, Forrest I, et al. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. 2020;75(11):1009-1016.

  8. Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of spirometry 2019 update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200(8):e70-e88.

  9. Benítez-Pérez RE, Torre-Bouscoulet L, Villca-Alá N, Del-Río-Hidalgo RF, Pérez-Padilla R, Vázquez-García JC, et al. Espirometría: recomendaciones y procedimiento. Neumol Cir Torax. 2016;75(2):173-190.

  10. Rodríguez Porres M. Interpretación de la espirometría en atención primaria. Respir Aten Prim. 2022;1:1-5.

  11. Milanese M, Anselmo M, Buscaglia S, Garra L, Goretti R, Parodi L, et al. COVID-19 6 months after hospital discharge: pulmonary function impairment and its heterogeneity. ERJ Open Res. 2021;7(3):00196-02021. doi: 10.1183/23120541.00196-2021.

  12. Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, Solis-Navarro L, Burgos F, Puppo H, et al. Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. Pulmonology. 2021;27(4):328-337. doi: 10.1016/j.pulmoe.2020.10.013.

  13. Arbillaga-Etxarri A, Lista-Paz A, Alcaraz-Serrano V, Escudero-Romero R, Herrero-Cortina B, Balañá Corberó A, et al. Fisioterapia respiratoria post-COVID-19: algoritmo de decisión terapéutica. Open Respiratory Archives. 2022;4(1):100139.

  14. Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021;9(7):747-754. doi: 10.1016/S2213-2600(21)00174-0.

  15. Moreno-Tetlacuilo LM, Gutiérrez K. Hombres, mujeres y la COVID-19. ¿Diferencias biológicas, genéricas o ambas? Bolet COVID-19 UNAM. 2020;1(6):3-6.

  16. Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;55(6):2001217.

  17. Zhao YM, Shang YM, Song WB, Li QQ, Xie H, Xu QF, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463.

  18. Rosero RJ, Polanco JP, Sánchez P, Hernández E, Pinzón JB, Lizcano F. Obesidad: un problema en la atención de Covid-19. Repert Med Cir. 2020;29(supl.1):10-14.




2020     |     www.medigraphic.com